GV 2019 GP, L.L.C., Ten Percent Owner at Decibel Therapeutics, holds 11.86M shares in Prime Medicine, Inc. (Ticker: PRME), holds 4.47M shares in Verve Therapeutics (Ticker: VERV), holds 819.63K shares in Decibel Therapeutics (Ticker: DBTX).
GV 2019 GP, L.L.C. latest transaction was an Uninformative Sell of $847.42K.
What was GV 2019 GP, L.L.C.'s most profitable transaction?
GV 2019 GP, L.L.C.’s most profitable transaction was an Informative Buy of PRME stock on October 26, 2022. The return on the trade was -9.10%.
What is GV 2019 GP, L.L.C.'s role in Decibel Therapeutics?
GV 2019 GP, L.L.C.'s role in Decibel Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.